##  [Novartis financial data](/investors/financial-data "Novartis financial data") 

 Novartis provides the following information on the company's strong financial performance since its creation in 1996.

 

 [ 

 

###  Annual results 

Novartis annual results conference, including media releases and year-to-date figures.

 

 

 ](/investors/financial-data/annual-results) [ 

 

###  Quarterly results 

View recent and archived quarterly results.

 

 

 ](/investors/financial-data/quarterly-results) [ 

 

###  SEC filings 

Use the SEC’s EDGAR system to search and review all US disclosure filings by Novartis.

 

 

 ](/investors/financial-data/sec-filings) 





 [ 

 

###  Fixed-income securities 

Learn about the fixed-income securities issued by Novartis.

 

 

 ](/investors/financial-data/fixed-income-securities) [ 

 

###  Product sales 

View net sales data of the top 20 brands in 2025.

 

 

 ](/investors/financial-data/product-sales) [ 

 

###  Expected currency impact 

Expected currency impact, if mid-August exchange rates prevail in 2026.

 

 

 ](/investors/financial-data/expected-currency-impact) 





 

 

 



 



 ![Business people walking on the Novartis Basel campus](/sites/novartis_com/files/styles/cta_image/public/2026-01/business-people-walking-on-novartis-basel-campus.jpg.webp?itok=SF5ucdX7 "Business people walking on the Novartis Basel campus") 

 

##  Reporting and transparency hub 

Read our regulatory filings; policies, codes and guidelines that govern our activities; and environmental, social and governance (ESG) disclosures.



 

 [Learn more](/investors/reporting-and-transparency-hub "Learn more")